Eukaryotic translation elongation factor 1 alpha 1 pseudogene 29 (EEF1A1P29)

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 29 is a processed pseudogene derived from the EEF1A1 gene, which encodes a central protein in the elongation phase of protein translation in eukaryotes[1]. Pseudogenes such as EEF1A1P29 are DNA sequences resembling known protein-coding genes but are typically nonfunctional due to mutations, truncations, or lack of necessary regulatory elements. EEF1A1P29 itself does not encode a protein product and is generally not directly involved in any cellular process or disease, though altered pseudogene expression can sometimes associate with human diseases, typically as a consequence of nearby gene regulation or genomic rearrangements[2][4]. No drugs, mechanisms of action, or clinical interventions are associated with this pseudogene. Key factual clarifications: - EEF1A1P29 is a pseudogene, not an active receptor, enzyme, transporter, or other classic drug target[2][4]. - The canonical full name is Eukaryotic translation elongation factor 1 alpha 1 pseudogene 29. - There is no evidence that EEF1A1P29 encodes a functional protein or serves as a direct therapeutic target[2]. - The gene has been referenced in datasets linked to cancer types, but these data are correlative and do not imply a therapeutic role[2]. EEF1A1P29 is best categorized structurally as a pseudogene and functionally as non-coding, with no established direct biological function, disease mechanism, or drug association.

Other names

EEF1A1 pseudogene 29EEF1A1P29[4][2]